BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Genetown

  Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Investor Conferences

  September 3, 2008

   · 

  1 min read
• Biotech Beach

  Somaxon Pharmaceuticals, Inc. Presents Pharmacological Data on Doxepin at the 21st European College of Neuropsychopharmacology Congress

  September 3, 2008

   · 

  1 min read
• Business

  Sucampo Pharmaceuticals, Inc. Limited Appoints New Head of Business Development

  September 3, 2008

   · 

  1 min read
• Business

  Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 8, 2008

  September 3, 2008

   · 

  1 min read
• Drug Development

  Neurocrine Biosciences, Inc. Announces Successful Elagolix PETAL Study in Endometriosis Phase II Study Meets Primary Bone Mineral Density and Secondary Efficacy Endpoints

  September 3, 2008

   · 

  7 min read
• Pharm Country

  Redpoint Bio Corporation to Present at the 19th Annual Wall Street Analyst Conference

  September 3, 2008

   · 

  1 min read
• Business

  Helix BioMedix, Inc. Announces License Agreement with Rodan & Fields, LLC

  September 3, 2008

   · 

  1 min read
• BioCapital

  NASDAQ Hearing Panel Grants Insmed Incorporated Request for Continued Listing

  September 3, 2008

   · 

  2 min read
• Business

  Resverlogix Corporation Board of Directors Update

  September 3, 2008

   · 

  3 min read
• Drug Development

  Alexza Pharmaceuticals, Inc.'s AZ-004 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients

  September 3, 2008

   · 

  12 min read